Skip to main content
Top
Published in: BMC Health Services Research 1/2017

Open Access 01-12-2017 | Research article

Sex differences in healthcare expenditures among adults with diabetes: evidence from the medical expenditure panel survey, 2002–2011

Authors: Joni S. Williams, Kinfe Bishu, Clara E. Dismuke, Leonard E. Egede

Published in: BMC Health Services Research | Issue 1/2017

Login to get access

Abstract

Background

The evidence assessing differences in medical costs between men and women with diabetes living in the United States is sparse; however, evidence suggests women generally have higher healthcare expenditures compared to men. Since little is known about these differences, the aim of this study was to assess differences in out-of-pocket (OOP) and total healthcare expenditures among adults with diabetes.

Methods

Data were used from 20,442 adults (≥18 years of age) with diabetes from the 2002–2011 Medical Expenditure Panel Survey. Dependent variables were OOP and total direct expenditures for multiple health services (prescription, office-based, inpatient, outpatient, emergency, dental, home healthcare, and other services). The independent variable was sex. Covariates included sociodemographic characteristics, comorbid conditions, and time. Sample demographics were summarized. Mean OOP and total direct expenditures for health services by sex status were analyzed. Regression models were performed to assess incremental costs of healthcare expenditures by sex among adults with diabetes.

Results

Fifty-six percent of the sample was composed of women. Unadjusted mean OOP costs were higher for women for prescriptions ($1177; 95% CI $1117–$1237 vs. $959; 95% CI $918–$1000; p < 0.001) compared to men. Unadjusted mean total direct expenditures were also higher for women for prescriptions ($3797; 95% CI $3660–$3934 vs. $3334; 95% CI $3208–$3460; p < 0.001) and home healthcare ($752; 95% CI $646–$858 vs. $397; 95% CI $332–$462; p < 0.001). When adjusting for covariates, higher OOP and total direct costs persisted for women for prescription services (OOP: $156; 95% CI $87–$225; p < 0.001 and total: $184; 95% CI $50–$318; p = 0.007). Women also paid > $50 OOP for office-based visits (p < 0.001) and > $55 total expenditures for home healthcare (p = 0.041) compared to men after adjustments.

Conclusions

Our findings show women with diabetes have higher OOP and total direct expenditures compared to men. Additional research is needed to investigate this disparity between men and women and to understand the associated drivers and clinical implications. Policy recommendations are warranted to minimize the higher burden of costs for women with diabetes.
Literature
1.
go back to reference Zhuo X, Zhang P, Barker L, Albright A, Thompson TJ, Gregg E. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care. 2014;37(9):2557–64.CrossRefPubMed Zhuo X, Zhang P, Barker L, Albright A, Thompson TJ, Gregg E. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care. 2014;37(9):2557–64.CrossRefPubMed
4.
go back to reference Ozieh MN, Bishu KG, Dismuke CE, Egede LE. Trends in health care expenditures in U.S. adults with diabetes: 2002–2011. Diabetes Care. 2015;38(10):1844–51.CrossRefPubMedPubMedCentral Ozieh MN, Bishu KG, Dismuke CE, Egede LE. Trends in health care expenditures in U.S. adults with diabetes: 2002–2011. Diabetes Care. 2015;38(10):1844–51.CrossRefPubMedPubMedCentral
5.
go back to reference Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Population Heatlh. 2010;8:29. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Population Heatlh. 2010;8:29.
6.
go back to reference Brandle M, Zhou H, Smith BRK, Marriott D, Burke R, Tabaei BP, et al. The direct medical cost of type 2 diabetes. Diabetes Care. 2003;26:2300–4.CrossRefPubMed Brandle M, Zhou H, Smith BRK, Marriott D, Burke R, Tabaei BP, et al. The direct medical cost of type 2 diabetes. Diabetes Care. 2003;26:2300–4.CrossRefPubMed
7.
go back to reference Hu R, Shi L, Pierre G, Zhu J, Lee D. Diabetes and medical expenditures among non-institutionalized U.S. adults. Diabetes Res Clin Pract. 2015;108:223–34.CrossRefPubMed Hu R, Shi L, Pierre G, Zhu J, Lee D. Diabetes and medical expenditures among non-institutionalized U.S. adults. Diabetes Res Clin Pract. 2015;108:223–34.CrossRefPubMed
8.
go back to reference Lee JM, Davis MM, Gebremariam A, Kim C. Age and sex differences in hospitalizations associated with diabetes. J Women’s Health. 2010;19(11):2033–42.CrossRef Lee JM, Davis MM, Gebremariam A, Kim C. Age and sex differences in hospitalizations associated with diabetes. J Women’s Health. 2010;19(11):2033–42.CrossRef
9.
go back to reference Asao K, McEwen LN, Lee JM, Herman WH. Ascertainment of outpatient visits by patients with diabetes: The National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS). J Diabetes Complications. 2015;29:650–8.CrossRefPubMedPubMedCentral Asao K, McEwen LN, Lee JM, Herman WH. Ascertainment of outpatient visits by patients with diabetes: The National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS). J Diabetes Complications. 2015;29:650–8.CrossRefPubMedPubMedCentral
10.
go back to reference Owens GM. Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm. 2008;14(3 Suppl):2–6.PubMed Owens GM. Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm. 2008;14(3 Suppl):2–6.PubMed
11.
go back to reference Bertakis KD, Azari R. Patient gender differences in the prediction of medical expenditures. J Womens Health. 2010;19:1925–32.CrossRef Bertakis KD, Azari R. Patient gender differences in the prediction of medical expenditures. J Womens Health. 2010;19:1925–32.CrossRef
12.
go back to reference Cohen SB, Ezzati-Rice T, Yu W. The utility of extended longitudinal profiles predicting future health care expenditures. Med Care. 2006;44:I45–53.PubMed Cohen SB, Ezzati-Rice T, Yu W. The utility of extended longitudinal profiles predicting future health care expenditures. Med Care. 2006;44:I45–53.PubMed
13.
go back to reference Hwang W, Weller W, Ireys H, Anderson G. Out-of-Pocket medical spending for care of chronic conditions. Health Aff. 2001;20(6):267–78.CrossRef Hwang W, Weller W, Ireys H, Anderson G. Out-of-Pocket medical spending for care of chronic conditions. Health Aff. 2001;20(6):267–78.CrossRef
14.
go back to reference Paez KA, Zhao L, Hwang W. Rising out-of-pocket spending for chronic conditions: a ten-year trend. Heatlh Affairs. 2009;28(1):15–25.CrossRef Paez KA, Zhao L, Hwang W. Rising out-of-pocket spending for chronic conditions: a ten-year trend. Heatlh Affairs. 2009;28(1):15–25.CrossRef
15.
go back to reference Birnbaum H, Leong S, Kabra A. Lifetime medical costs for women: cardiovascular disease, diabetes, and stress urinary incontinence. Womens Health Issues. 2003;13:204–13.CrossRefPubMed Birnbaum H, Leong S, Kabra A. Lifetime medical costs for women: cardiovascular disease, diabetes, and stress urinary incontinence. Womens Health Issues. 2003;13:204–13.CrossRefPubMed
21.
go back to reference Egede LE, Bishu KG, Walker RJ, Dismuke CE. Impact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004–2011. J Affect Disord. 2016;195:119–26.CrossRefPubMed Egede LE, Bishu KG, Walker RJ, Dismuke CE. Impact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004–2011. J Affect Disord. 2016;195:119–26.CrossRefPubMed
22.
go back to reference Egede LE, Lynch CP, Gebregziabher M, Hunt KJ, Echols C, Gilbert GE, Mauldin PD. Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes. J Gen Intern Med. 2012;28(2):208–15.CrossRefPubMedPubMedCentral Egede LE, Lynch CP, Gebregziabher M, Hunt KJ, Echols C, Gilbert GE, Mauldin PD. Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes. J Gen Intern Med. 2012;28(2):208–15.CrossRefPubMedPubMedCentral
23.
go back to reference Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48(5):562–70.CrossRefPubMed Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48(5):562–70.CrossRefPubMed
24.
go back to reference Cameroon AC, Trivedi PK. Microeconometrics using stata. Texas: StataCorp LP, revised edition College Station; 2010. Cameroon AC, Trivedi PK. Microeconometrics using stata. Texas: StataCorp LP, revised edition College Station; 2010.
25.
go back to reference Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461–94.CrossRefPubMed Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461–94.CrossRefPubMed
26.
go back to reference Belotti F, Deb P, Manning WG, Norton EC. twopm: Two-part models. Stata J. 2015;15(1):3–20. Belotti F, Deb P, Manning WG, Norton EC. twopm: Two-part models. Stata J. 2015;15(1):3–20.
27.
go back to reference Fu AZ, Qiu Y, Radican L, Wells BJ. Healthcare and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care. 2009;32(12):2187–92.CrossRefPubMedPubMedCentral Fu AZ, Qiu Y, Radican L, Wells BJ. Healthcare and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care. 2009;32(12):2187–92.CrossRefPubMedPubMedCentral
28.
go back to reference Barnett SBL, Nurmagambetov TA. Costs of asthma in the United States: 2002–2007. J Allergy Clin Immunol. 2011;127(1):145–52.CrossRefPubMed Barnett SBL, Nurmagambetov TA. Costs of asthma in the United States: 2002–2007. J Allergy Clin Immunol. 2011;127(1):145–52.CrossRefPubMed
29.
go back to reference Mihaylova B, Briggs A, O’Hhagan A, Thompson SG. Review of statistical methods for analyzing healthcare resources and costs. Health Econ. 2011;20:897–916.CrossRefPubMed Mihaylova B, Briggs A, O’Hhagan A, Thompson SG. Review of statistical methods for analyzing healthcare resources and costs. Health Econ. 2011;20:897–916.CrossRefPubMed
30.
go back to reference Desai PR, Lawson KA, Barner JC, Rascati KL. Identifying patent characteristics associated with high Schizophrenia-related direct medical costs in community-dwelling patents. J Manag Care Pharm. 2013;19(6):468–77.PubMed Desai PR, Lawson KA, Barner JC, Rascati KL. Identifying patent characteristics associated with high Schizophrenia-related direct medical costs in community-dwelling patents. J Manag Care Pharm. 2013;19(6):468–77.PubMed
31.
go back to reference StataCorp. Stata: Release 14. Statistical Software. College Station: StataCorp LP; 2015. StataCorp. Stata: Release 14. Statistical Software. College Station: StataCorp LP; 2015.
32.
go back to reference Leung MY, Pollack LM, Colditz GA, Chang SH. Life years lost and lifetime health care expenditures associated with diabetes in the U.S., National Health Interview Survey, 1997–2000. Diabetes Care. 2015;38(3):460–8.CrossRefPubMed Leung MY, Pollack LM, Colditz GA, Chang SH. Life years lost and lifetime health care expenditures associated with diabetes in the U.S., National Health Interview Survey, 1997–2000. Diabetes Care. 2015;38(3):460–8.CrossRefPubMed
33.
go back to reference Heisler M, Wagner TH, Piette JD. Patient Strategies to Cope with High Prescription Medication Costs: Who is Cutting Back on Necessities, Increasing Debt, or Underusing Medications? J Behav Med. 2005;28(1):43–51.CrossRefPubMed Heisler M, Wagner TH, Piette JD. Patient Strategies to Cope with High Prescription Medication Costs: Who is Cutting Back on Necessities, Increasing Debt, or Underusing Medications? J Behav Med. 2005;28(1):43–51.CrossRefPubMed
34.
go back to reference Piette JD, Heisler M, Wager TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27:384–91.CrossRefPubMed Piette JD, Heisler M, Wager TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27:384–91.CrossRefPubMed
35.
go back to reference Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79(11):1554–6.CrossRefPubMedPubMedCentral Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79(11):1554–6.CrossRefPubMedPubMedCentral
Metadata
Title
Sex differences in healthcare expenditures among adults with diabetes: evidence from the medical expenditure panel survey, 2002–2011
Authors
Joni S. Williams
Kinfe Bishu
Clara E. Dismuke
Leonard E. Egede
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2017
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-017-2178-3

Other articles of this Issue 1/2017

BMC Health Services Research 1/2017 Go to the issue